Explorer
Cipla
Business
Cipla Q1 Profit Jumps 10% To Rs 1,298 Crore, Revenue At Rs 6,957 Crore
Business
Cipla CEO Says US Drug Pricing Order Unlikely To Impact Indian Generics
Business
Cipla Q4 Results: Profit Rises Over 30%, Announces Rs 16 Dividend
Personal Finance
Best Stocks To Buy Today: Cipla, Voltas Among Top 5 Picks For January 1, 2025
Personal Finance
Planning To Invest In Pharma Firms? Here Are The Top Stocks To Look Out For In 2024
Business
Stock Market Opening Bell: Sensex, Nifty Up Marginally, Bharat Petroleum Shares Jump Over 3%
Business
Dr Reddy's Q2 Result: Pharma Firm's PAT Jumps 33 Per Cent To Rs 1,482 Crore
Health
Moderna Becomes Fourth Vaccine To Get Approval In India. Here’s A Quick Peek On The Other Three
India
'No Definitive Pact' On Commercial Supply Of Moderna Jabs To India, Says Cipla After DCGI Nod
Health
Cipla Gets DCGI Nod To Import Moderna's Covid Jab For Emergency Use In India
India
'Rules Should Be Same For All': SII Seeks Indemnity Protection After Moderna & Pfizer
Health
What Is Antibody Cocktail Treatment? How It Helps In Fight Against Coronavirus - Details Here
News Reels
Advertisement
Advertisement




















